Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. November 2016 07:05 ET | Quelle: Immunovaccine Inc.

Neoepitope Peptides Formulated in Immunovaccine's DepoVax(TM) Vaccine Platform Show Significant Positive Results in Preclinical Studies

HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 3, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
01. November 2016 07:05 ET | Quelle: Immunovaccine Inc.

Immunovaccine Appoints Gabriela Rosu, M.D., as Company's First Chief Medical Officer

HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 1, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
13. Oktober 2016 07:05 ET | Quelle: Immunovaccine Inc.

Immunovaccine Announces Positive Phase 1 Topline Data for DepoVax(TM)-based Respiratory Syncytial Virus Vaccine Candidate

HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 13, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
11. Oktober 2016 07:05 ET | Quelle: Immunovaccine Inc.

Positive Preclinical Data for Immunovaccine's DepoVax(TM)-based Malarial Vaccine Presented at 2016 World Vaccine Congress Europe

HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 11, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
06. Oktober 2016 07:05 ET | Quelle: Immunovaccine Inc.

Immunovaccine to Present at 2016 BIO Investor Forum

HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 6, 2016) - Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will...
03. Oktober 2016 07:05 ET | Quelle: Immunovaccine Inc.

Immunovaccine Announces Transition of Chief Financial Officer Role

HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 3, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
23. September 2016 07:05 ET | Quelle: Immunovaccine Inc.

Researchers to Present Data on Immunovaccine's Infectious Disease Pipeline at Three International Conferences

HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 23, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical-stage vaccine and immunotherapy company,...
20. September 2016 07:05 ET | Quelle: Immunovaccine Inc.

Immunovaccine to Present Pre-Clinical Data at the 2016 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival

HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 20, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical-stage vaccine and immunotherapy company,...
08. September 2016 07:05 ET | Quelle: Immunovaccine Inc.

Immunovaccine Announces Dosing of First Patient in Phase 1b Clinical Trial for DPX-Survivac in Combination With Incyte's IDO1 Enzyme Inhibitor Epacadostat

HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 8, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
01. September 2016 07:05 ET | Quelle: Immunovaccine Inc.

Immunovaccine to Present at 2016 Rodman & Renshaw Global Investment Conference

HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 1, 2016) - Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will...

Vorherige Seite

Nächste Seite